Stay updated on Fenebrutinib vs Ocrelizumab in Primary Progressive MS Clinical Trial

Sign up to get notified when there's something new on the Fenebrutinib vs Ocrelizumab in Primary Progressive MS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fenebrutinib vs Ocrelizumab in Primary Progressive MS Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Cali, Colombia was added to the study locations and Santiago de Cali, Colombia was removed.
    Difference
    0.3%
    Check dated 2025-10-28T05:10:05.000Z thumbnail image
  3. Check
    34 days ago
    Change Detected
    Summary
    Updated the page to v3.2.0 with a government-operating status notice and related links; removed the previous v3.1.0 reference.
    Difference
    2%
    Check dated 2025-10-06T16:00:23.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    Updates add current dates, new locations/addresses, and an updated revision version; older locations and outdated addresses are removed. Overall, it reflects a refresh of core identifiers and contact details.
    Difference
    3%
    Check dated 2025-09-29T09:58:30.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Localized the country name from Mexico to México in the address and updated the revision to v3.0.2; the 'Back to Top' link was removed.
    Difference
    1%
    Check dated 2025-09-15T00:21:54.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.1%
    Check dated 2025-09-07T20:50:33.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has been updated to include new facility names and locations, increasing the total number of study locations from 187 to 189. Additionally, the last update date has been changed to August 2025.
    Difference
    14%
    Check dated 2025-08-31T12:56:55.000Z thumbnail image

Stay in the know with updates to Fenebrutinib vs Ocrelizumab in Primary Progressive MS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fenebrutinib vs Ocrelizumab in Primary Progressive MS Clinical Trial page.